
    
      Non-small cell lung cancer (NSCLC) patients with chemotherapy will be enrolled. Patients will
      be thoroughly informed about all aspects of the study activity schedule and all regulatory
      requirements that must be satisfied for informed consent. Only patients who give consent to
      participate in this study and meet all other inclusion and exclusion criteria will be
      eligible to enroll into this study. ICD-10 fatigue criteria, Brief Fatigue Inventory-Taiwan
      Form (BFI-T), the visual analog scale (VAS) for appetite and Functional Assessment of Cancer
      Therapy-General quality of life questionnaire (FACT-G7) will be used to evaluate patients'
      fatigue and quality of life. Patients who enrolled in this observational study will complete
      the evaluation and questionnaire of fatigue and quality of life according to clinical
      schedule. The first survey (baseline) will be collected after enrollment, the further surveys
      will be completed every three chemotherapy cycles following subject's chemotherapy schedule
      and after finish the whole course of chemotherapy. Subject demographic and disease-related
      information and routine laboratory data will also be collected from medical record for
      analysis.
    
  